Trial of Pevonedistat Plus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer

NCT03228186 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

40

Enrollment

OTHER

Sponsor class

Stopped Pharmaceutical company discontinued the study drug.

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Pevonedistat
DRUG: Docetaxel

Sponsor

University of Michigan Rogel Cancer Center